A prospective randomized trial of ICRF-187 for prevention of cumulative doxorubicin-induced cardiac toxicity in women with breast cancer

Cancer Treat Rev. 1990 Sep;17(2-3):161-3. doi: 10.1016/0305-7372(90)90041-d.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Breast Neoplasms / drug therapy*
  • Cardiomyopathies / chemically induced
  • Cardiomyopathies / prevention & control*
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Doxorubicin / adverse effects*
  • Female
  • Fluorouracil / administration & dosage
  • Heart / drug effects*
  • Humans
  • Prospective Studies
  • Razoxane / therapeutic use*

Substances

  • Razoxane
  • Doxorubicin
  • Cyclophosphamide
  • Fluorouracil